Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Acute Mania Investigation
2008-000281-23Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of melatonin in bipolar disorder (BD), mania and hypomania, sponsored by University of Oxford. Primary endpoint: Change in Young Mania Rating Scale. Started Oct 2010; status: completed.
02
Drugs
melatonin
03
Conditions
bipolar disorder (BD)maniahypomania
Beyond the preview
Go deeper on 2008-000281-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000281-23.